IIM
ABEO icon

INTECH Investment Management’s Abeona Therapeutics ABEO Stock Holding History

INTECH Investment Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1K Sell
10,207
-1,986
-16% -$10.9K ﹤0.01% 2025
2026
Q1 		$54.6K Sell
12,193
-9,056
-43% -$45.3K ﹤0.01% 1997
2025
Q4 		$112K Sell
21,249
-3,927
-16% -$19.8K ﹤0.01% 2136
2025
Q3 		$133K Buy
25,176
+4,127
+20% +$26.2K ﹤0.01% 2183
2025
Q2 		$120K Buy
+21,049
New +$120K ﹤0.01% 2250

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

INTECH Investment Management's ABEO Position: Q2 2026 in Review

INTECH Investment Management reduced its Abeona Therapeutics (ABEO) stake by 16% in Q2 2026, selling an estimated $10.9K and leaving 10,207 shares worth $63.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

INTECH Investment Management first reported a position in ABEO in Q2 2025 and has held it in 5 quarters since. The position peaked at $133K in Q3 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • INTECH Investment Management held 10,207 shares of Abeona Therapeutics worth $63.1K as of Q2 2026.
  • INTECH Investment Management sold 1,986 Abeona Therapeutics shares in Q2 2026, an estimated $10.9K.
  • Abeona Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2025 holding.
  • INTECH Investment Management first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • INTECH Investment Management's Abeona Therapeutics position peaked at $133K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.